Pemgarda Injection
FDA Label NDC 81960-031

46 label sections · Submitted to the FDA by Invivyd, Inc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Invivyd, Inc for the product Pemgarda (NDC 81960-031). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding fact sheet for healthcare providers: emergency use authorization of pemgarda (pemivibart), table of contents*, warning: anaphylaxis, 1 emergency use authorization for pemgarda, 2 dosage and administration, 2.1 dosage for emergency use of pemgarda, 2.2 dosage adjustment in specific populations, 2.3dose preparation and administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.